CNE000001CL7
CNE000001CL7
JIANGSU KANION PHARMACEUTICAL C
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 7.02B EUR | 6.66B EUR | 7.72B EUR |
Enterprise Value | 5.67B EUR | 4.71B EUR | 5.68B EUR |
Valuation Multiples | |||
Trailing P/E | 22.55x | 21.47x | 23.68x |
Forward P/E | 11.38x | -- | -- |
Price to Sales | 2.12x | 1.97x | 2.25x |
Price to Book | 1.41x | 1.34x | 1.58x |
EV/Revenue | 1.71x | 1.39x | 1.66x |
EV/EBITDA | 13.51x | 12x | 13.54x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -9.45% | -2.54% | -1.37% |